We are live on ! Find out more
EVGN icon

Evogene

22 hedge funds and large institutions have $39.3M invested in Evogene in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

22% more funds holding

Funds holding: 1822 (+4)

0.03% more ownership

Funds ownership: 2.99%3.02% (+0.03%)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

22% less capital invested

Capital invested by funds: $50.1M → $39.3M (-$10.9M)

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$15.6M -$936K -16,351 -5%
UBS Group
2
UBS Group
Switzerland
$4.88M +$765K +13,368 +16%
Bank of America
3
Bank of America
North Carolina
$4.08M +$211K +3,693 +5%
CI
4
Clal Insurance
Israel
$3.06M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.05M
Goldman Sachs
6
Goldman Sachs
New York
$1.94M -$577K -10,086 -21%
Canada Pension Plan Investment Board
7
Canada Pension Plan Investment Board
Ontario, Canada
$1.43M
MMH
8
Menora Mivtachim Holdings
Israel
$1.32M
MCM
9
Moon Capital Management
New York
$1.05M +$323K +5,645 +38%
JP Morgan Chase
10
JP Morgan Chase
New York
$816K
Wellington Management Group
11
Wellington Management Group
Massachusetts
$803K -$489K -8,546 -35%
SM
12
Senvest Management
New York
$702K +$153K +2,680 +24%
HSBC Holdings
13
HSBC Holdings
United Kingdom
$510K +$572K +10,000 New
Barclays
14
Barclays
United Kingdom
$252K
EVC
15
Eidelman Virant Capital
Missouri
$243K +$163K +2,840 +147%
SWM
16
Stockman Wealth Management
Montana
$190K -$3.72K -65 -2%
Jane Street
17
Jane Street
New York
$149K +$168K +2,929 New
Morgan Stanley
18
Morgan Stanley
New York
$93K +$104K +1,825 New
NEAM
19
New England Asset Management
Connecticut
$77K +$85.8K +1,500 New
AIM
20
ARK Investment Management
Florida
$34K +$38.1K +665 New
Citigroup
21
Citigroup
New York
$24K -$18.2K -318 -40%
Wells Fargo
22
Wells Fargo
California
$5K
TRCT
23
Tower Research Capital (TRC)
New York
-$1K -8 Closed

EVGN Hedge Fund Activity: Q4 2016 in Review

22 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2016, worth a combined $39.3M — down 22% from $50.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new EVGN positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was UBS Group, adding an estimated $765K. The largest seller was Waddell & Reed Financial, cutting an estimated $936K.

  • 22 institutional investors held Evogene (EVGN) as of Q4 2016, up from 18 in Q3 2016.
  • Funds reported $39.3M of Evogene stock for Q4 2016, down 22% quarter-over-quarter.
  • 5 funds opened new Evogene positions in Q4 2016 and 1 closed out, a net change of +4 holders.
  • The largest Evogene buyer in Q4 2016 was UBS Group, an estimated $765K added.
  • The largest Evogene seller in Q4 2016 was Waddell & Reed Financial, an estimated $936K sold.

Based on aggregated 13F filings for Q4 2016.